Scientists Develop ‘Highly Active’ HIV Antiviral Drug

Enterprise Television-Scientists Develop ‘Highly Active’ HIV Antiviral Drug

The Russian Central Research Institute of Epidemiology has developed a new gene therapy medicine for people who have the HIV, head of the federal health and epidemic watchdog Rospotrebnadzor, Anna Popova, said on Wednesday.

“The Central Research Institute of Epidemiology of Rospotrebnadzor created a fundamentally new drug for gene therapy, gene prophylactic treatment and molecular vaccination against HIV,” Popova said on the sidelines of an international conference on HIV and AIDS in Moscow.

“A highly active antiviral drug called Dinavir, which will soon be clinically tested, has been created.”

The official noted that Russia was facing a number of problems related to the treatment of HIV and AIDS, including high prices for treatment and lack of proper medication.

Facebook Comments

All rights reserved. Kindly share news, opinion, contributions and press releases with us at editor@enterprisenetwork.africa